Efficacy and Feasibility of Sorafenib as a Maintenance Agent after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: an update

Publication date: Available online 18 April 2019Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Giorgia Battipaglia, Radwan Massoud, Syed Osman Ahmed, Ollivier Legrand, Jean El Cheikh, Riad Youniss, Mahmoud Aljurf, Mohamad Mohty, Ali Bazarbachi
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research